Alexander Ehlgen
Director/Board Member at TACALYX GmbH
Network origin in Alexander Ehlgen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany.
96
| Private Company | Investment Managers | 96 |
University of Bonn
24
| College/University | Other Consumer Services | 24 |
Boehringer Ingelheim (Venture Capital)
 Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.
14
| Operating Division | Investment Managers | 14 |
TACALYX GmbH
 TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services TACALYX GmbH engages in the discovery and development of Tumor Associated Carbohydrate Antigenantibodies to treat cancer. The company was founded by Peter Sondermann, Peter H. Seeberger, and Oren Moscovitz and is headquartered in Berlin, Germany.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Aignostics GmbH
 Aignostics GmbH Packaged SoftwareTechnology Services Aignostics GmbH provides diagnostics services. The company is headquartered in Berlin, Germany.
1
| Holding Company | Packaged Software | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alexander Ehlgen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Bridgepoint Advisers Ltd.
 Bridgepoint Advisers Ltd. Investment ManagersFinance Bridgepoint Advisers Ltd (Bridgepoint Advisers) is a private equity subsidiary of Bridgepoint Group Ltd. founded in 1984. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Analyst | |
| K+S AG | Chemicals: Specialty | Public Communications Contact Corporate Officer/Principal | |
| CEWE STIFTUNG & CO. KGAA | Specialty Stores | Private Equity Investor Corporate Officer/Principal | |
| Maastricht University | College/University | Graduate Degree Graduate Degree Graduate Degree | |
tbg Technologie-Beteiligungs GmbH
 tbg Technologie-Beteiligungs GmbH Financial ConglomeratesFinance tbg Technologie-Beteiligungs GmbH is a German technology investment company that focuses on investing in innovative technology startups. The company is ultimately controlled by the Government of Germany and is based in Bonn, Germany. The CEOs of the company are Walter Auel, Andreas Höck, Markus Schladt. | Financial Conglomerates | Private Equity Investor Private Equity Investor | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Universität zu Köln | College/University | Graduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
| University of Vienna | College/University | Undergraduate Degree | |
| Technische Universität München | College/University | Graduate Degree Graduate Degree | |
| Ruhr-Universität Bochum | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| Technische Universität Darmstadt | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| University of St. Gallen | College/University | Graduate Degree Undergraduate Degree | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree Doctorate Degree | |
| University of Münster | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| RWTH Aachen University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Hamburg | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of Giessen | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree Doctorate Degree | |
| Freie Universität Berlin | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
| University of Hagen | College/University | Masters Business Admin Graduate Degree | |
| University of Duisburg-Essen | College/University | Masters Business Admin Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Bielefeld | College/University | Doctorate Degree Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Doctorate Degree Doctorate Degree | |
| EVONIK INDUSTRIES AG | Chemicals: Major Diversified | Director/Board Member Corporate Officer/Principal | |
EBS Universität für Wirtschaft und Recht gGmbH
 EBS Universität für Wirtschaft und Recht gGmbH Other Consumer ServicesConsumer Services EBS Universität für Wirtschaft und Recht gGmbH functions as a college or university. Its services include academic, coaching@EBS, career services center, EBS languages center, accommodation database and EBS mediations services. The company is headquartered in Wiesbaden, Germany. | College/University | Undergraduate Degree Doctorate Degree | |
SuppreMol GmbH
 SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Corteva Agriscience Germany GmbH
 Corteva Agriscience Germany GmbH Wholesale DistributorsDistribution Services Part of Corteva, Inc., Corteva Agriscience Germany GmbH is a company that wholesales agricultural chemicals. The company is based in Munich, Germany. The CEO of the company is Rudolf Fuchs. | Wholesale Distributors | Corporate Officer/Principal | |
| Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree Graduate Degree | |
| Max Planck Institute of Biochemistry | College/University | Corporate Officer/Principal Doctorate Degree | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Evonik Venture Capital GmbH
 Evonik Venture Capital GmbH Investment ManagersFinance Evonik Venture Capital GmbH (Evonik Venture Capital) is the venture capital subsidiary of Evonik Operations GmbH, itself a subsidiary of RAG-Stiftung. The firm was founded in 2007 and is headquartered in Hanau, Germany. | Investment Managers | Chief Executive Officer Private Equity Investor | |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| NIT Northern Institute of Technology Management gGmbh | College/University | Masters Business Admin | |
| McKinsey & Co. Vietnam Ltd. | Corporate Officer/Principal | ||
Bodyport, Inc.
 Bodyport, Inc. Packaged SoftwareTechnology Services Bodyport, Inc. manufactures sensor fitted weighing scales. It offers scale that measures weight like others do, but also measures blood pressure, heart rate, heart rate variability, and arterial stiffness through a user's feet. The company was founded by Corey Centen and Sarah Smith and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member Director/Board Member | |
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tilos Therapeutics, Inc.
 Tilos Therapeutics, Inc. BiotechnologyHealth Technology Tilos Therapeutics, Inc. designs and develops biotechnology products such as developing new treatments for cancer, fibrosis and autoimmune disease. It develops antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company was founded by Howard L. Weiner in 2016 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
Abexxa Biologics, Inc.
 Abexxa Biologics, Inc. Pharmaceuticals: MajorHealth Technology AbeXXa Biologics, Inc. is engaged in biopharmaceutical services. The company was founded by Jon Weidanz and Debra Weidanz in 2015 and is headquartered in Arlington, TX. | Pharmaceuticals: Major | Director/Board Member | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Rinri Therapeutics Ltd.
 Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Rgenta Therapeutics, Inc.
 Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Rgenta Therapeutics, Inc. manufactures medicines for oncology and neurological disorders. The company was founded by Simon Xi, Travis Wager, and Zhiping Weng and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ESADE Business School | College/University | Graduate Degree Graduate Degree | |
Syte GmbH
 Syte GmbH Packaged SoftwareTechnology Services Syte GmbH provides AI software for real estate developers and brokers to gather information about properties. The company is based in Münster, Germany. The German company's flexible integration plans allow for customization to individual requirements. The company was founded in 2021 by David Nellessen, who has been the CEO since 2021. | Packaged Software | Director/Board Member | |
Sentien Biotechnologies, Inc.
 Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member |
Statistics
International
| Germany | 34 |
| United States | 7 |
| United Kingdom | 3 |
| France | 3 |
| Netherlands | 2 |
Sectoral
| Consumer Services | 28 |
| Health Technology | 10 |
| Finance | 5 |
| Commercial Services | 4 |
| Process Industries | 3 |
Operational
| Director/Board Member | 164 |
| Private Equity Investor | 101 |
| Corporate Officer/Principal | 64 |
| Graduate Degree | 52 |
| Undergraduate Degree | 40 |
Most connected contacts
| Insiders | |
|---|---|
| Holger N. Reithinger | 25 |
| Curtis MacDonald | 20 |
| Klaus Schollmeier | 17 |
| Sebastian Thrun | 17 |
| Karlheinz Schmelig | 11 |
| Frank Kalkbrenner | 11 |
| Angelika Vlachou | 11 |
| Maurice Kügler | 10 |
| Peter Neubeck | 10 |
| Peter H. Seeberger | 10 |
| Martin Ostermayer | 10 |
| Martin Heidecker | 9 |
| Andreas Olmes | 9 |
| Bernhard Mohr | 9 |
| Klaus Lehmann | 8 |
- Stock Market
- Insiders
- Alexander Ehlgen
- Company connections